Prot #MT-3921-G01: A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single Ascending Dose of MT-3921 in Subjects with Acute Spinal Cord Injury

Project: Research project

Project Details

StatusActive
Effective start/end date4/27/204/27/23

Funding

  • DP Clinical, Inc. (Prot #MT-3921-G01)
  • Mitsubishi Tanabe Pharma America, Inc. (Prot #MT-3921-G01)